The influence of anesthesia on intraoperative neurophysiological monitoring during spinal surgeries. 2019

J Benuska, and M Plisova, and M Zabka, and J Horvath, and P Tisovsky, and K Novorolsky

BACKGROUND Intraoperative neuromonitoring using tc-MEPs satisfactorily detects motor tract integrity changes during spinal surgery. However, tc-MEP is affected by anesthesia and other factors, in which the stimulation threshold increases because the waveform amplitude decreases over time with the accumulation and boluses of anesthetics. METHODS We conducted a retrospective study of 139 patients. The average age was 30 years. Tc-MEPs were recorded bilaterally from the tibialis anterior muscle and the abductor hallucis muscle. Statistical tests were used to investigate the changes to evaluate anesthetic effects. RESULTS There were no significant differences in tc-MEP amplitude change (%) between the groups of propofol (13 %), remifentanil (22 %) and sufentanil (26 %, p < 0.01). Significant differences were found between the groups of propofol, remifentanil, and sufentanil (20 %) and bolus sufentanil (‒30 %), and bolus ketamine (730 %, p < 0.008). Major differences were observed between bolus sufentanil (‒30 %) and bolus ketamine (730 %, p < 0.001). When comparing tc-MEPs with no amplitude, no significant difference was found between the groups of propofol (26 %), remifentanil (24 %), and sufentanil (28 %, p < 0.007). Substantial difference was found between the groups of propofol, remifentanil, and sufentanil (mean 26 %) and the group where ketamine boluses were administered. We didn't observe any loss of amplitude (0 %, p < 0.0002). CONCLUSIONS IONM may be useless in patients where boluses of sufentanil are administered and also with Medical Research Council grades 3 and below. Consider applying IONM in patients with severe spinal deformity along with a higher age of over 50 and neurological deficit. Increasing stimulus intensity or facilitation techniques may be considered to improve the usefulness of tc-MEP. Our concept of findings supports the neurophysiological monitoring findings in other studies (Tab. 10, Ref. 45).

UI MeSH Term Description Entries
D007649 Ketamine A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors. 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone,CI-581,Calipsol,Calypsol,Kalipsol,Ketalar,Ketamine Hydrochloride,Ketanest,Ketaset,CI 581,CI581
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077208 Remifentanil A piperidine-propionate derivative and opioid analgesic structurally related to FENTANYL. It functions as a short-acting MU OPIOID RECEPTOR agonist, and is used as an analgesic during induction or maintenance of general anesthesia, following surgery, during childbirth, and in mechanically ventilated patients under intensive care. 3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic Acid Methyl Ester,GI 87084B,GI-87084B,GI87084B,Remifentanil Hydrochloride,Remifentanil Monohydrochloride,Ultiva
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000758 Anesthesia A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013131 Spine The spinal or vertebral column. Spinal Column,Vertebrae,Vertebral Column,Vertebra,Column, Spinal,Column, Vertebral,Columns, Spinal,Columns, Vertebral,Spinal Columns,Vertebral Columns
D015742 Propofol An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS. Disoprofol,2,6-Bis(1-methylethyl)phenol,2,6-Diisopropylphenol,Aquafol,Diprivan,Disoprivan,Fresofol,ICI-35,868,ICI-35868,Ivofol,Propofol Abbott,Propofol Fresenius,Propofol MCT,Propofol Rovi,Propofol-Lipuro,Recofol,2,6 Diisopropylphenol,ICI 35,868,ICI 35868,ICI35,868,ICI35868
D017409 Sufentanil An opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent. R-30730,Sufenta,Sufentanil Citrate,Sufentanil Curasan,Sufentanil-Hameln,Sufentanil-Ratiopharm,Sulfentanil,Sulfentanyl,Citrate, Sufentanil,Curasan, Sufentanil,R 30730,R30730,Sufentanil Hameln,Sufentanil Ratiopharm,SufentanilHameln,SufentanilRatiopharm
D018686 Anesthetics, Intravenous Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) Intravenous Anesthetic,Intravenous Anesthetics,Anesthetic, Intravenous

Related Publications

J Benuska, and M Plisova, and M Zabka, and J Horvath, and P Tisovsky, and K Novorolsky
June 2013, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society,
J Benuska, and M Plisova, and M Zabka, and J Horvath, and P Tisovsky, and K Novorolsky
October 2021, Current opinion in anaesthesiology,
J Benuska, and M Plisova, and M Zabka, and J Horvath, and P Tisovsky, and K Novorolsky
June 2020, The Neurodiagnostic journal,
J Benuska, and M Plisova, and M Zabka, and J Horvath, and P Tisovsky, and K Novorolsky
September 2012, Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,
J Benuska, and M Plisova, and M Zabka, and J Horvath, and P Tisovsky, and K Novorolsky
December 2013, Journal of clinical monitoring and computing,
J Benuska, and M Plisova, and M Zabka, and J Horvath, and P Tisovsky, and K Novorolsky
January 2012, Masui. The Japanese journal of anesthesiology,
J Benuska, and M Plisova, and M Zabka, and J Horvath, and P Tisovsky, and K Novorolsky
November 2023, Cureus,
J Benuska, and M Plisova, and M Zabka, and J Horvath, and P Tisovsky, and K Novorolsky
July 2022, Cureus,
J Benuska, and M Plisova, and M Zabka, and J Horvath, and P Tisovsky, and K Novorolsky
January 2014, TheScientificWorldJournal,
J Benuska, and M Plisova, and M Zabka, and J Horvath, and P Tisovsky, and K Novorolsky
September 2015, World journal of clinical cases,
Copied contents to your clipboard!